| Purity: | 99.8 |
|---|---|
| Brand Name: | Huisheng |
| Grade Standard: | Medicine Grade |
| Type: | Auxiliaries and Other Medicinal Chemicals |
| CAS No.: | 82034-46-6 |
| Place of Origin: | China (Mainland) |
Quick Details
Specifications
Semaglutide is a new generation GLP-1Chemicalbook (Glucagon-like peptide-1) analogue developed by NovoNordisk, a Danish company. Semaglutide is a long-acting formulation based on the basic structure of Liraglutide, which is more effective in the treatment of type 2 diabetes.
Novo Nordisk has completed six PhaseIIIa studies for its Somarutide injection and submitted a new drug registration application to the U.S. Food and Drug Administration (FDA) on December 5, 2016 for the weekly Chemicalbook injection of Somarutide.An application for Marketing Authorization (MAA) has also been submitted to the European Medicines Agency (EMA).A once-daily oral formulation of Sommarutide, on the other hand, is currently in phase III.
Novo Nordisk has completed six PhaseIIIa studies for its Somarutide injection and submitted a new drug registration application to the U.S. Food and Drug Administration (FDA) on December 5, 2016 for the weekly Chemicalbook injection of Somarutide.An application for Marketing Authorization (MAA) has also been submitted to the European Medicines Agency (EMA).A once-daily oral formulation of Sommarutide, on the other hand, is currently in phase III.